Metabolic Syndrome: Individual Components in Women who Had Preeclampsia History and Normal Risk Pregnancy
Keywords:Metabolic Syndrome X, Pre-eclampsia, Insulinresistence, Cardiovascular Diseases.
Introduction: Preeclampsia is a serious complication of pregnancy and childbirth that can contribute to the late onset of cardiovascular risk factors, among which the metabolic syndrome. Objective: identifying the prevalence of metabolic syndrome and its individual components in women who had preeclampsia and normal risk of pregnancy, evaluated five years after delivery. Method: analytical and descriptive, cross-sectional study with data collection conducted from March to December 2011 in a maternity hospital school, Natal-RN-Brazil. The sample included 70 women who had previous preeclampsia and 75 with normal pregnancy, selected by simple random probability sampling method. Results: It appeared as a cardiovascular risk factor, with statistical significance for metabolic syndrome p = 0.042, but also the fasting glucose levels p = 0.030, HDL cholesterol p = 0.049, systolic and diastolic pressure p <0.001. Conclusion: Therefore, preeclampsia appears as a potential risk factor for metabolic syndrome. Hence as long-term cardiovascular risk factor.
Stekkinger E, Scholten R, van der Vlugt M, van Dijk A, Janssen M, SpaandermanM. Metabolic syndrome and the risk for recurrent pre-eclampsia: a retrospective cohort study.BJOG. 2013 Jul; 120(8):979-86.
Montenegro CAB, Rezende Filho J. Rezende obstetrÃcia fundamental. Rio de Janeiro: Guanabara Koogan, 2014.
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, LIoyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011. Update: a guideline from the American Heart Association. Circulation. 2011;123:1243-62.
George E. M. Granger, JP. Endothelin: key mediator ofhypertension in preeclampsia. Am J Hypertens. 2011 Sep;24(9): 964â€“9.
Bilhartz TD, Bilhartz PA, Bilhartz TN, Bilhartz RD. Making use of a natural stress test: Pregnancy and cardiovascularrisk. J. Womens Health. 2011;20:695â€“701.
Kandaraki E, Christakou C, Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome... and vice versa. Arq Bras Endocrinol Metabol. 2009 Mar;53(2):227-37.
Mabry, R. M. et al. Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review. Diabet Med. 2010 May;27(5):593- 7.
Wang, W. et al. Epidemiological Investigation of Metabolic Syndrome and Analysis of Relevant Factors in North-eastern China. J Int Med Res. 2010 Jan/Feb;38(1):150-9.
Jover A, Corbella E, MuÃ±oz A, MillÃ¡n J, PintÃ³ X, Mangas A, et al. Prevalencia Del sÃndrome metabÃ³lico y de sus componentes en pacientes con sÃndrome coronario agudo. Rev Esp Cardiol. 2011;64 (7):579-86.
Lu J, Zhao YY, Qiao J, Zhang HJ, Ge L, Wei Y. A follow-up study of women with a history of severe preeclampsia: relatioship between metabolic syndrome and preeclampsia. Chin Med J. 2011;124(5):775-79.
Mottillo S1, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis. J Am Col lCardiol. 2010 Sep 28;56(14):1113-32.
LeÃ£o LSCS, Barros EG, Koifman RJ. PrevalÃªncia de SÃndrome MetabÃ³lica em Adultos Referenciados para AmbulatÃ³rio de NutriÃ§Ã£o no Rio de Janeiro, Brasil. Rev Bras Cardiol. 2010 Mar/Apr; 23(2): 93-100.
Smith GN, Pudwell J, Walker M, Wen SW. Ten-year, thirty-year, and lifetime cardiovascular disease risk estimates following a pregnancy complicated by preeclampsia. J. Obstet. Gynaecol. Can. 2012;34(9): 830-5.
Azevedo MF, Costa EC, Oliveira AIN, Silva IBO, Marinho JCDB, Rodrigues JAMR, et al. NÃveis pressÃ³ricos elevados em mulheres com sÃndrome dos ovÃ¡rios policÃsticos: prevalÃªncia e fatores de risco associados. Rev Bras Ginecol Obstet. 2011;33(1):31-6.
Brasil. Sociedade Brasileira de Cardiologia. Sociedade Brasileira de HipertensÃ£o. Sociedade Brasileira de Nefrologia. VI Diretrizes Brasileiras de HipertensÃ£o. Arq Bras Cardiol 2010; 95(supl.1):1-51.
World Health Organization (WHO). Physical status: the use and interpretation ofanthropometry. Report of a WHO Expert Committee.WHO Tech Rep Ser. 1995;854: 1-452.
International Diabetes Federation (IDF). The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation (IDF) [Internet]. 2006 [cited 2013 Jun 10]; [about. 24 p.]. Available from: http://www.idf.org/webdata/docs/Metac_syndrome_def.pdf.
Brasil. Diretrizes e normas regulamentadoras de pesquisa em seres humanos. ResoluÃ§Ã£o nÂº 466 de 12 de dezembro de 2012. BrasÃlia (DF): MinistÃ©rio da SaÃºde; 2012.
Niu JM , Lei Q , LÃ¼ LJ , Wen JY , Lin XH , Duan DM , et. al. Evaluation of the diagnostic criteria of gestational metabolic syndrome and analysis of the risk factors. Zhonghua Fu Chan Ke Za Zhi 2013 Feb;48 (2):92-7.
Yang JJ, Lee SA, Choi JY, Song M, Han S, Yoon HS, et. al. Subsequent risk of metabolic syndrome in women with a history of preeclampsia: data from the Health Examinees Study. J Epidemiol. 2015 Mar;25(4):281-8.
Smith GN, Pudwell J, Walker M, Wen SW. Risk estimation of metabolic syndrome atone and three years after a pregnancy complicated by preeclampsia. J Obstet Gynaecol Can.2012 Sep;34(9):836-41.
Pierin MG, Marroni SN, Taveira LAF, Bensenor IJM. Controle da hipertensÃ£o arterial e fatores associados na atenÃ§Ã£o primÃ¡ria em Unidades BÃ¡sicas de SaÃºde localizadas na RegiÃ£o Oeste da cidade de SÃ£o Paulo.CiÃªncia & SaÃºde Coletiva [Online], 2011;16(Supl.1):1389-1400.
Kim JY, Mun HS, Lee BK, Yoon SB, Choi EY, Min PK, et. al. Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease. Yonsei Med J. 2010;51:676â€“682.
Allen R, Rogozinska E, Sivarajasingam P, Khan KS, Thangaratinam S. Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis. Acta Obstet Gynecol Scand. 2014 Oct; 93(10): 973-85.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).